PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

eWeLL Co.,Ltd.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (13)

eWeLL Co.,Ltd. owes ¥0.19 for every ¥1 it owns. Net profit rose 35% in the year to Dec 2025, and grew 34% a year on average over 3 years.

Compared with Healthcare companies in Japan · latest annual results Dec 2025.

P/E ratio

29.7

Investors pay ¥29.7 for every ¥1 of eWeLL Co.,Ltd.'s yearly profit, higher than 82% of Healthcare companies in Japan.

P/B ratio

8.99

The share price is 8.99 times eWeLL Co.,Ltd.'s book value per share, higher than 96% of Healthcare companies in Japan.

Market cap

¥31.8 B

The total market value of all of eWeLL Co.,Ltd.'s shares at today's price (share price × number of shares), larger than 58% of Healthcare companies in Japan. PosiCap size class: Mini Cap.

Net worth (book value)

¥3.5 B

What eWeLL Co.,Ltd. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).

Book value per share

¥260.98

Net worth divided by the number of shares. The share price of ¥2,345 is 9.0 times this, which is the P/B above.

Return on equity (ROE)

37.8%

eWeLL Co.,Ltd. earned 37.8% on its shareholders' money over the last year, higher than almost all Healthcare companies in Japan.

Owes vs Owns

0.19×

eWeLL Co.,Ltd. owes ¥0.19 for every ¥1 it owns (low).

Dividend yield

0.89%

eWeLL Co.,Ltd. pays 0.89% of its share price as dividends a year, lower than 96% of dividend-paying Healthcare companies in Japan.

Revenue growth

+32%

Revenue rose 32% in the year to Dec 2025, and grew 28% a year on average over 3 years.

Profit growth

+35%

Net profit rose 35% in the year to Dec 2025, and grew 34% a year on average over 3 years.

Profit margin

32.1%

eWeLL Co.,Ltd. keeps ¥32 of every ¥100 of revenue as net profit.

Cash quality

1.2×

Cash from eWeLL Co.,Ltd.'s business was 1.2× its reported profit in the year to Dec 2025 — its profit turned into cash.

Interest cover

4548.7×

eWeLL Co.,Ltd.'s operating profit covered its interest costs 4548.7 times in the year to Dec 2025.

Questions

What is eWeLL Co.,Ltd.'s P/E ratio?

Investors pay ¥29.7 for every ¥1 of eWeLL Co.,Ltd.'s yearly profit, higher than 82% of Healthcare companies in Japan.

How is P/B calculated on PositoAI?

P/B is market cap divided by net worth from the latest balance sheet. For eWeLL Co.,Ltd.: ¥31.8 B ÷ ¥3.5 B (30 Jun 2026) = 9.0.

What is eWeLL Co.,Ltd.'s return on equity?

eWeLL Co.,Ltd. earned 37.8% on its shareholders' money over the last year, higher than almost all Healthcare companies in Japan.

How much does eWeLL Co.,Ltd. owe compared with what it owns?

eWeLL Co.,Ltd. owes ¥0.19 for every ¥1 it owns (low).

Does eWeLL Co.,Ltd. pay a dividend?

Yes. eWeLL Co.,Ltd. pays 0.89% of its share price as dividends a year, lower than 96% of dividend-paying Healthcare companies in Japan.

Is eWeLL Co.,Ltd.'s revenue growing?

Revenue rose 32% in the year to Dec 2025, and grew 28% a year on average over 3 years.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.